ENTREPRISESIL Y A 4J — 1 MIN DE LECTURE
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
PAR SUSANOO NEWSSOURCE : TECHCRUNCH AI
Envedadrug discoveryAI biotechGLP-1clinical trialsSeries funding
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.